Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
04/25/2011
Trade Name:
Lamictal XR
Generic or Proper Name (*):
lamotrigine
Indications Studied:
Monotherapy in patients 13 years of age and older with partial seizures who are receiving therapy with a single antiepileptic drug (AED)
Therapeutic Category:
Anticonvulsant
Ages Studied:
13 years and older
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Blind/Open Label
No Patients:
17
No Centers:
65
No Countries:
7
BPCA(B), PREA(P):
P
-
-